New Zealand medical college concerned about youth vaping increase
The Royal New Zealand College of General Practitioners is expressing concern over the rapid increase in the number of young people using electronic cigarettes.
Medical director Bryan Betty informed the special committee studying the Smoke-Free Environment Amendment Act that the college supports the use of e-cigarettes as a smoking cessation tool. However, he cautioned that it may take several decades to fully understand their medical effectiveness.
He stated that there is a rising trend among teenagers of using electronic cigarettes, and there is increasing evidence indicating that this habit may lead to an increased incidence of asthma as well as the possibility of lung damage.
Two years ago, about 25% of the electronic cigarettes sold contained nicotine, but now this percentage has skyrocketed to 80%.
Dr. Betty stated that the problem with nicotine is its addictive properties, making it difficult to quit once addicted. It can also raise blood pressure, increase anxiety, and interfere with the brain development of young people. These are the main concerns regarding nicotine.
Disclaimer: 1. This article is compiled from third-party information and is intended for industry communication and learning only. 2. The views expressed in this article are not representative of 2FIRSTS, and 2FIRSTS cannot confirm the accuracy or truthfulness of the article's content. The compilation of this article is solely for industry communication and research purposes. 3. Due to the limitation of the compilation level, the compiled article may not express the same views as the original article. Please refer to the original article for accuracy. 4. When it comes to any statements and positions involving domestic matters, Hong Kong, Macau, Taiwan, and foreign affairs, 2FIRSTS is fully aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
